FDA Guidance Outlines Procedures for Handling, Retaining BA, BE Test Samples
May 31, 2024
The FDA’s guidance on the quantity of bioavailability (BA) and bioequivalence (BE) testing samples to be retained by NDA applicants and contract research organizations (CRO) contains both draft and final language focusing on both the test article and reference standard.